Literature DB >> 24687962

Ageing and dementia in a longitudinal study of a cohort with Down syndrome.

Janet Carr1, Suzanne Collins.   

Abstract

BACKGROUND: A population sample of people with Down syndrome has been studied from infancy and has now been followed up again at age 47 years.
METHODS: Intelligence and language skills were tested and daily living skills assessed. Memory/cognitive deterioration was examined using two test instruments.
RESULTS: Scores on verbal tests of intelligence changed little. Those on a non-verbal test, on self-help skills and on both memory tests showed some decline, even when the scores of those already suffering from dementia were discounted.
CONCLUSIONS: At age 47, scores on most tests of even the majority of the cohort (i.e. those not definitely diagnosed with dementia) showed some decline. While this includes the scores of people who may subsequently develop dementia, it may also reflect the normal ageing process in this population.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Down syndrome; dementia; longitudinal

Mesh:

Year:  2014        PMID: 24687962     DOI: 10.1111/jar.12093

Source DB:  PubMed          Journal:  J Appl Res Intellect Disabil        ISSN: 1360-2322


  5 in total

Review 1.  Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms.

Authors:  Amelia J Anderson-Mooney; Frederick A Schmitt; Elizabeth Head; Ira T Lott; Kenneth M Heilman
Journal:  Brain Cogn       Date:  2016-02-27       Impact factor: 2.310

Review 2.  The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies.

Authors:  Bianca Alexandra Lautarescu; Anthony John Holland; Shahid H Zaman
Journal:  Neuropsychol Rev       Date:  2017-03-13       Impact factor: 7.444

3.  Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients.

Authors:  Makiko Shinomoto; Takashi Kasai; Harutsugu Tatebe; Masaki Kondo; Takuma Ohmichi; Masafumi Morimoto; Tomohiro Chiyonobu; Naoto Terada; David Allsop; Isao Yokota; Toshiki Mizuno; Takahiko Tokuda
Journal:  PLoS One       Date:  2019-04-05       Impact factor: 3.240

4.  Executive Functioning in Adults with Down Syndrome: Machine-Learning-Based Prediction of Inhibitory Capacity.

Authors:  Mario Fernando Jojoa-Acosta; Sara Signo-Miguel; Maria Begoña Garcia-Zapirain; Mercè Gimeno-Santos; Amaia Méndez-Zorrilla; Chandan J Vaidya; Marta Molins-Sauri; Myriam Guerra-Balic; Olga Bruna-Rabassa
Journal:  Int J Environ Res Public Health       Date:  2021-10-14       Impact factor: 3.390

5.  Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome.

Authors:  Carla M Startin; Sarah Hamburg; Rosalyn Hithersay; Tamara Al-Janabi; Kin Y Mok; John Hardy; Andre Strydom
Journal:  Alzheimers Dement       Date:  2018-11-28       Impact factor: 21.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.